OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q2 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,262 | -93.3% | 16,007 | -85.0% | 0.00% | -100.0% |
| Q4 2021 | $746,000 | -75.2% | 106,970 | -85.9% | 0.00% | -80.0% |
| Q4 2019 | $3,004,000 | -48.3% | 760,490 | -60.2% | 0.01% | -54.5% |
| Q3 2019 | $5,805,000 | -38.9% | 1,909,478 | -11.5% | 0.02% | -35.3% |
| Q2 2019 | $9,496,000 | +38.8% | 2,158,149 | +25.2% | 0.03% | +30.8% |
| Q1 2019 | $6,842,000 | +44.8% | 1,723,456 | +45.1% | 0.03% | +23.8% |
| Q4 2018 | $4,726,000 | +36.6% | 1,187,508 | +136.0% | 0.02% | +61.5% |
| Q3 2018 | $3,461,000 | – | 503,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |